Gross Profit Margin (Quarterly) Chart

View Gross Profit Margin (Quarterly) for DYAI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Gross Profit Margin (Quarterly) Chart
Start Trial

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2004. Start Trial.
Date Value
June 30, 2026 -2.39%
March 31, 2026 28.72%
December 31, 2025 31.99%
September 30, 2025 12.07%
June 30, 2025 36.52%
March 31, 2025 24.36%
December 31, 2024 56.84%
September 30, 2024 79.78%
June 30, 2024 21.74%
March 31, 2024 56.99%
December 31, 2023 49.00%
September 30, 2023 73.33%
June 30, 2023 5.28%
March 31, 2023 25.67%
December 31, 2022 5.27%
September 30, 2022 31.47%
June 30, 2022 37.56%
March 31, 2022 37.58%
December 31, 2021 -5.84%
September 30, 2021 43.35%
June 30, 2021 11.48%
March 31, 2021 15.16%
December 31, 2020 26.11%
September 30, 2020 35.88%
June 30, 2020 -19.07%
Date Value
March 31, 2020 11.79%
December 31, 2019 1.94%
September 30, 2019 15.34%
June 30, 2019 17.55%
March 31, 2019 18.53%
December 31, 2018 26.04%
September 30, 2018 7.45%
June 30, 2018 19.96%
March 31, 2018 20.35%
December 31, 2017 11.91%
September 30, 2017 19.08%
June 30, 2017 3.66%
March 31, 2017 0.00%
December 31, 2016 15.01%
September 30, 2016
June 30, 2016 8.72%
March 31, 2016 1.96%
December 31, 2015 -6.33%
September 30, 2015 83.61%
June 30, 2015 40.14%
March 31, 2015 39.50%
December 31, 2014 33.01%
September 30, 2014 40.96%
June 30, 2014 29.50%
March 31, 2014 33.71%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Agenus, Inc. 98.50%
Amgen, Inc. 72.08%
Anika Therapeutics, Inc. 65.15%
BioCryst Pharmaceuticals, Inc. 98.01%
Imunon, Inc. --

Gross Profit Margin (Quarterly) Related Metrics